As of December 2023 Zoetis has a market cap of $86.94 Billion. This makes Zoetis the world's 166th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $86.94 B | 27.29% |
2022 | $68.30 B | -40.84% |
2021 | $115.45 B | 46.79% |
2020 | $78.65 B | 24.98% |
2019 | $62.93 B | 53.42% |
2018 | $41.02 B | 16.86% |
2017 | $35.10 B | 32.8% |
2016 | $26.43 B | 10.91% |
2015 | $23.83 B | 10.49% |
2014 | $21.57 B | 31.98% |
2013 | $16.34 B |
On Dec 10th, 2023 the market cap of Zoetis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $160.97 B | 85.15% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $552.16 B | 535.09% | ๐บ๐ธ USA |
![]() Sanofi SNY | $118.66 B | 36.49% | ๐ซ๐ท France |
![]() Merck MRK | $265.43 B | 205.30% | ๐บ๐ธ USA |
![]() Phibro Animal Health
PAHC | $0.44 B | -99.48% | ๐บ๐ธ USA |
![]() Kindred Biosciences
KIN | $0.42 B | -99.52% | ๐บ๐ธ USA |
![]() Heska Corporation
HSKA | $1.30 B | -98.49% | ๐บ๐ธ USA |